Actively Recruiting
Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
Led by University of British Columbia · Updated on 2023-12-06
842
Participants Needed
1
Research Sites
297 weeks
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The PERSON-JIA Trial is a cluster-randomized trial testing the use of Shared Decision Making (SDM) with families for treatment of children with arthritis. The intervention is a discussion between physicians and families at the time of diagnosis that uses computer-generated personalized outcome reports generated by previously developed prediction algorithms. By using information provided by thousands of families, the investigators have developed a way of providing answers to common questions asked by patients and their families at diagnosis. We will test whether a structured discussion and shared decision between families and doctors (guided by the patient's personal report) will improve the tailoring of treatment to the child and control of their disease. The personal report is called the PERSON-JIA report and presents the child's expected disease severity, the likelihood the child will be arthritis free by age 18 and the chance treatments will be effective and/or have side effects. This way, answers to these questions can be shared by physicians and families to weigh potential benefits and harms according to family values and preferences. The investigators expect that using the personalized report in a frank and thoughtful discussion will help physicians and families make better decisions about managing the child's disease. This in turn will result in better disease control, greater family engagement and satisfaction with care and better-tailored treatment. If so, this will be a ground-breaking way of using information provided by families and doctors to improve the care provided to and the outcomes of children with arthritis in Canada.
CONDITIONS
Official Title
Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consent to include their information in the CAPRI JIA Registry
- Consent to participate in the PERSON-JIA trial and complete additional questionnaires
- Agree to allow recording of their medical visit if randomly selected
- Diagnosis of Juvenile Idiopathic Arthritis (JIA) following ILAR criteria
- Newly diagnosed with JIA within the last month
- Diagnosed by a pediatric rheumatologist participating in this study
- Not yet started treatment or only treated with NSAIDs or joint injections
You will not qualify if you...
- Diagnosed with systemic arthritis category of JIA
- Family unable to complete study forms in English or French
- Already started systemic corticosteroids or any Disease Modifying Anti-Rheumatic Drugs (DMARDs)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BC Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Actively Recruiting
Research Team
J
Jaime Guzman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here